Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jan;107(2):181-9.
doi: 10.1172/JCI10934.

Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways

L Rui  1 , V Aguirre, J K Kim, G I Shulman, A Lee, A Corbould, A Dunaif, M F White
Affiliations

Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways

L Rui et al. J Clin Invest. 2001 Jan.

Abstract

Serine/threonine phosphorylation of IRS-1 might inhibit insulin signaling, but the relevant phosphorylation sites are difficult to identify in cultured cells and to validate in isolated tissues. Recently, we discovered that recombinant NH2-terminal Jun kinase phosphorylates IRS-1 at Ser307, which inhibits insulin-stimulated tyrosine phosphorylation of IRS-1. To monitor phosphorylation of Ser307 in various cell and tissue backgrounds, we prepared a phosphospecific polyclonal antibody designated alphapSer307. This antibody revealed that TNF-alpha, IGF-1, or insulin stimulated phosphorylation of IRS-1 at Ser307 in 3T3-L1 preadipocytes and adipocytes. Insulin injected into mice or rats also stimulated phosphorylation of Ser307 on IRS-1 immunoprecipitated from muscle; moreover, Ser307 was phosphorylated in human muscle during the hyperinsulinemic euglycemic clamp. Experiments in 3T3-L1 preadipocytes and adipocytes revealed that insulin-stimulated phosphorylation of Ser307 was inhibited by LY294002 or wortmannin, whereas TNF-alpha-stimulated phosphorylation was inhibited by PD98059. Thus, distinct kinase pathways might converge at Ser307 to mediate feedback or heterologous inhibition of IRS-1 signaling to counterregulate the insulin response.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ser307 in IRS-1 mediates the inhibitory effect of anisomycin on insulin-induced tyrosyl phosphorylation of IRS-1. CHO cells were transiently transfected with plasmids (10 μg) encoding IRS-1 or IRS-1S307A. Twenty-four hours later, cells were deprived of serum overnight and preincubated for 30 minutes with 5 μg/ml anisomycin before 50 nM insulin stimulation for an additional 5 minutes. (a) Proteins (30 μg) in cell lysates were resolved by SDS-PAGE and immunoblotted with anti-phosphotyrosine. (b) The same blot was reprobed with αIRS-1. The migration of molecular weight standards, IRS-1, and IR is indicated.
Figure 2
Figure 2
Anisomycin stimulates phosphorylation of IRS-1 on Ser307. (a and b) CHO (a) or 293 (b) cells were treated with 5 μg/ml anisomycin (aniso) for 30 minutes. IRS-1 was immunoprecipitated (IP) with αIRS-1 and immunoblotted with αpS307. The same blot was stripped and reprobed with αIRS-1. (c) αpS307 was preincubated on ice for 15 minutes with 5-μg phospho-Ser307 peptide (pS307) or non-phospho-Ser307 (S307) peptide. αIRS-1 immunoprecipitates from control or anisomycin-stimulated CHO cells were immunoblotted with αpS307 in the presence of pS307 or S307, respectively. (d) CHO cells were transfected transiently with 5-μg plasmids encoding HA-tagged IRS-1 or IRS-1S307A. Cells were treated with 5 μg/ml anisomycin for 30 minutes. HA-tagged IRS-1 and IRS-1S307A in cell lysates were immunoprecipitated with αHA. The αHA immunoprecipitates were divided evenly into two and immunoblotted with αpS307 and αIRS-1, respectively.
Figure 3
Figure 3
TNF-α stimulates phosphorylation of IRS-1 on Ser307 and inhibits insulin-promoted tyrosyl phosphorylation of IRS-1 and activation of ERK1/2. (a) 3T3-L1 adipocytes were pretreated with 20 ng/ml TNF-α for 5 hours before 50 nM insulin stimulation for 10 minutes. Proteins (40 μg) in cell lysates were immunoblotted with anti-phosphotyrosine and anti–phospho-MAPK, respectively. (b and c) 3T3-L1 preadipocytes (b) and adipocytes (c) were stimulated with 20 ng/ml TNF-α for 30 minutes. IRS-1 in cell lysates was immunoprecipitated with αIRS-1 and immunoblotted with αpS307. The same blots were stripped and reprobed with αIRS-1. (d) The 3T3-L1 adipocytes were stimulated with 20 ng/ml TNF-α for the indicated time. IRS-1 immunoprecipitates were immunoblotted with αpS307.
Figure 4
Figure 4
Insulin and IGF-1 stimulate phosphorylation of IRS-1 on Ser307 in both 3T3-L1 preadipocytes and adipocytes. (a) 3T3-L1 preadipocytes were stimulated with 100 nM insulin for the indicated time. IRS-1 in cell lysates was immunoprecipitated with αIRS-1 and immunoblotted with αpS307. The same blot was stripped and reprobed with αIRS-1. (b) 3T3-L1 preadipocytes and adipocytes were stimulated for 30 minutes with 100 nM insulin (Ins) and 100 ng/ml IGF-1 (IGF), respectively. IRS-1 immunoprecipitates were immunoblotted with αpS307. The same blot was stripped and reprobed with αIRS-1.
Figure 5
Figure 5
Insulin promotes phosphorylation of IRS-1 on Ser307in mouse, rat, and human skeletal muscle. (a) Saline or 5 U human insulin was injected as a bolus into the inferior vena cava of anesthetized mice. Soleus muscle was isolated 5 minutes later and homogenized. IRS-1 was immunoprecipitated with αIRS-1 and immunoblotted with αpS307. The same blots were stripped and reprobed with αIRS-1. (b) Insulin (5 U) was injected intraperitoneally into anesthetized rat. Saline was used as control. Soleus muscle was isolated 5 minutes later and homogenized. IRS-1 immunoprecipitates were immunoblotted with αpS307 or αIRS-1. Phospho-Ser307 was quantitated by phosphoimaging and normalized to IRS-1 level. The data were presented as mean ± SEM (three rats for each group; AP < 0.02). (c) Normal volunteer subjects were subjected to hyperinsulinemic euglycemic clamp. Muscle biopsies were obtained after insulin-clamp for 0 or 15 minutes and homogenized. IRS-1 immunoprecipitates were immunoblotted with αpS307. The data represent one of three independent experiments.
Figure 6
Figure 6
Two distinct pathways mediate Ser307 phosphorylation on IRS-1 induced by insulin/IGF-1 and TNF-α. (a) The 3T3-L1 preadipocytes were preincubated for 30 minutes with 20 μM LY294002 or 100 nM wortmannin (Wort) before stimulation for an additional 30 minutes with 100 nM insulin, 100 ng/ml IGF-1, or 20 ng/ml TNF-α. Proteins (50 μg) in the cell lysates were immunoblotted directly with antibodies against phospho-Akt or phospho-MAPK; or IRS-1 was immunoprecipitated from the lysates with αIRS-1 and immunoblotted with αpS307 or with αIRS-1. (b) The 3T3-L1 preadipocytes were preincubated for 30 minutes with 100 μM PD98059 before stimulation for an additional 30 minutes with 100 nM insulin, 100 ng/ml IGF-1, or 20 ng/ml TNF-α. IRS-1 in cell lysates was immunoprecipitated with αIRS-1. Half of the αIRS-1 immunoprecipitates were immunoblotted with αpS307, and half were immunoblotted with αIRS-1. (c) The 3T3-L1 preadipocytes were preincubated for 30 minutes with the indicated concentration of PD98059 before stimulation for an additional 30 minutes with 20 ng/ml TNF-α. Immunopurified IRS-1 was immunoblotted with αpS307. Cell extracts were immunoblotted with anti–phospho-MAPK.
Figure 7
Figure 7
TNF-α and insulin act synergistically to promote phosphorylation of Ser307 in IRS-1. The 3T3-L1 preadipocytes were treated for 30 minutes with 20 ng/ml TNF-α and 100 nM insulin either separately or simultaneously. IRS-1 in cell lysates was immunoprecipitated with αIRS-1 and immunoblotted with αpS307.
Figure 8
Figure 8
Kinase(s) other than JNK phosphorylate Ser307 in IRS-1. (a) The 3T3-L1 preadipocytes were preincubated for 30 minutes with or without 100 μM PD98059 before stimulation for an additional 15 minutes with 20 ng/ml TNF-α. JNK-1 was immunoprecipitated with αJNK-1, and subjected to an in vitro kinase assay using GST-cJun as a substrate (top). Cell lysates were immunoblotted with anti–phospho-MAPK (bottom). (b) The 3T3-L1 preadipocytes were preincubated for 30 minutes with or without 20 μM LY294002 before stimulation for an additional 10 minutes with 100 nM insulin. JNK-1 was immunoprecipitated with αJNK1, and subjected to an in vitro kinase assay using GST-cJun as a substrate.
Figure 9
Figure 9
Models for the function of Ser307 phosphorylation. Upon insulin stimulation, IRS-1 is tyrosyl-phosphorylated by the IR, resulting in the activation of PI 3-kinase that mediates Ser307 phosphorylation. Ser307 phosphorylation subsequently inhibits the ability of IRS-1 to be further tyrosyl phosphorylated by the IR and to propagate insulin signaling. An increase in Ser307 phosphorylation, such as that possibly trigged by TNF-α in chronic obesity, also induces insulin resistance. As β cells compensate for insulin insensitivity with compensatory hyperinsulinemia, chronic insulin stimulation induces more Ser307 phosphorylation through the PI 3-kinase pathway, thus further increasing the pool of inactive, Ser307 phosphorylated IRS-1. This vicious cycle might continue until hyperinsulinemia fails to compensate for insulin resistance.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Withers DJ, White MF. Insulin action and type 2 diabetes: lessons from knockout mice. Curr Opin Endocrinol Diab. 1999;6:141–145.
    1. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Review. 1997;5:177–269.
    1. DeFronzo RA, Prato SD. Insulin resistance and diabetes mellitus. J Diabetes Complications. 1996;10:243–245. - PubMed
    1. DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1997;73:1294–1301. - PubMed
    1. Kulkarni RN, et al. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 1999;96:329–339. - PubMed

Publication types

MeSH terms

-